Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZILRETTA safely and effectively. See full prescribing information for ZILRETTA. ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), for intra-articular use Initial U.S. Approval: 1957
Medication labelWhy this: Advisory · dailymed-prescription
ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is indicated as an intra-articular injection for the management of osteoarthritis pain of the knee. Limitation of Use The efficacy and safety of repeat administration of ZILRETTA have not been demonstrated. [see Dosage and Administration (2.1)].
- generic_name
- triamcinolone acetonide extended-release injectable suspension
- brand_name
- triamcinolone acetonide, diluent
- product_names
- triamcinolone acetonide extended-release injectable suspension, triamcinolone acetonide, diluent
- ndc
- 65250-003, 65250-003-01, 65250-001, 65250-001-01, 65250-002, 65250-002-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en